4//SEC Filing
Kay Mark A 4
Accession 0001209191-20-038662
CIK 0001664106other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:00 PM ET
Size
8.0 KB
Accession
0001209191-20-038662
Insider Transaction Report
Form 4
Kay Mark A
Director
Transactions
- Award
Stock Option (right to buy)
2020-06-19+10,000→ 10,000 totalExercise: $7.96Exp: 2030-06-19→ Common Stock (10,000 underlying) - Award
Restricted Stock Units
2020-06-19+2,199→ 2,199 total→ Common Stock (2,199 underlying)
Footnotes (3)
- [F1]All of the options will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of LogicBio Therapeutics, Inc. (the "Company") 2021 Annual Meeting of Stockholders, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan (the "2018 Plan").
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]All of the RSUs will vest on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001752537
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:00 PM ET
- Size
- 8.0 KB